<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Peripartum hysterectomy for management of hemorrhage</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Peripartum hysterectomy for management of hemorrhage</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Peripartum hysterectomy for management of hemorrhage</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniela A Carusi, MD, MSc</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Howard T Sharp, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Peripartum hysterectomy can be defined as a hysterectomy performed at the time, or within 24 hours, of delivery. Another definition is a hysterectomy performed any time from delivery to discharge from the same hospitalization. This topic will review the surgical planning, key operative points, and postoperative care for peripartum hysterectomy. </p><p>Related topics can be found separately and include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3311.html" rel="external">"Hysterectomy: Abdominal (open) route"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3301.html" rel="external">"Overview of preoperative evaluation and preparation for gynecologic surgery"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transgender and gender diverse individuals.</p><p class="headingAnchor" id="H3261011085"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence</strong> – Based on population-level data, the peripartum hysterectomy rate is approximately 1 per 1000 deliveries (eg, 0.1 percent) [<a href="#rid1">1,2</a>]. Incidence varies by setting. The highest incidence is reported in lower middle-income countries (3 in 1000 births, 95% CI 2.5-3.5) and the lowest incidence in high-income countries (0.7 in 1000 births, 95% CI 0.5-0.8 [<a href="#rid2">2</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – In addition to abnormal placentation, other significant risk factors for peripartum hysterectomy include advanced maternal age and parity, previous cesarean delivery, multiple gestations, antepartum bleeding, preeclampsia, bleeding disorders, and the use of assisted reproductive technologies [<a href="#rid2">2-10</a>]. </p><p></p><p class="bulletIndent1">A meta-analysis of 154 studies that included over 14,400 emergency peripartum hysterectomies reported [<a href="#rid2">2</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Most common overall indications</strong> – Placental pathology (38.0 percent, 95% CI 33.9-42.4), uterine atony (27.0 percent, 95% CI 24.6-29.5), and uterine rupture (21.2 percent, 95% CI 17.8-25.0).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lower middle-income settings</strong> – Uterine rupture (44.5 percent, 95% CI 36.6-52.7).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>High-income settings</strong> – Placental pathology (48.4 percent, 95% CI 43.5-53.4).</p><p></p><p class="bulletIndent1">While most patients with these risk factors will not experience major hemorrhage or hysterectomy, patients who have multiple risk factors, a history of postpartum hemorrhage, or history of cesarean birth are most likely to benefit from delivering in a setting where hysterectomy is readily available if needed.</p><p></p><p class="headingAnchor" id="H4"><span class="h1">SURGICAL PLANNING</span><span class="headingEndMark"> — </span>The procedure may be planned or performed in an emergency situation. The most common indication for emergency procedures is severe uterine hemorrhage that cannot be controlled by conservative measures. Such hemorrhage is most commonly due to abnormal placentation or uterine atony, with each accounting for 30 to 50 percent of peripartum hysterectomies [<a href="#rid11">11-14</a>]. Other potential causes include uterine rupture, leiomyomas, and laceration of uterine vessels [<a href="#rid5">5,15</a>]. Planned peripartum hysterectomy may be performed in patients with an antepartum diagnosis of placenta accreta, or more rarely for stage IA2 and IB1 cervical carcinoma or very large fibroids [<a href="#rid16">16,17</a>]. Infection appears to be an important contributor to peripartum hysterectomy. Not only is severe postpartum pelvic infection a potential indication for the procedure, but uteri removed for atony also show a relatively high rate of infection and inflammation on pathologic analysis [<a href="#rid16">16</a>].</p><p>The obstetrician should be prepared for the potential need to perform emergency peripartum hysterectomy, especially in patients with significant risk factors or heavy postpartum bleeding. Hysterectomy is not commonly performed on labor and delivery units; depending on local operating room resources, a general operating room may be necessary. An institution-specific labor and delivery unit checklist of equipment, other supplies, and action items for managing emergency hysterectomy is highly recommended and complies with the Hemorrhage Safety Bundle described by the United States National Partnership for Maternal Safety  (<a class="graphic graphic_table graphicRef93723" href="/z/d/graphic/93723.html" rel="external">table 1</a>) [<a href="#rid18">18</a>].</p><p>In emergency situations, a sequence of conservative measures to control uterine hemorrhage is attempted before resorting to invasive or surgical procedures  (<a class="graphic graphic_table graphicRef73412" href="/z/d/graphic/73412.html" rel="external">table 2</a> and <a class="graphic graphic_figure graphicRef126212" href="/z/d/graphic/126212.html" rel="external">figure 1</a>). If an intervention does not succeed, the next treatment in the sequence should be swiftly instituted. Conservative measures should be employed with the goal of avoiding the morbidity and sterilization that comes with hysterectomy. For those patients who inevitably require hysterectomy, immediate performance of the procedure (without using multiple conservative measures) leads to a lower transfusion requirement and possibly less morbidity [<a href="#rid19">19</a>]. Moreover, there is increased blood loss with increased duration of time before performance of hysterectomy. Thus, conservative measures should be used in quick succession, and preparation for hysterectomy should begin promptly in cases of massive hemorrhage or maternal instability. (See  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p class="headingAnchor" id="H1022164473"><span class="h2">Preoperative risk assessment</span><span class="headingEndMark"> — </span>Sometimes the obstetrician can anticipate the possible need for peripartum hysterectomy based on the patient's risk factors. This enables patient preparation and counseling in the antenatal period, detailed surgical planning, and possibly avoidance of an emergency procedure. This is true primarily for women with abnormal placentation.</p><p>Most patients with placenta accreta, increta, or percreta will undergo hysterectomy at delivery (79 of 133 patients [60 percent] in one study [<a href="#rid20">20</a>]). Placenta previa is associated with an approximately 5 percent risk of hysterectomy, usually in cases with placenta accreta [<a href="#rid21">21</a>]. The frequency of abnormal placentation rises substantially as the number of prior cesarean deliveries increases, as well as with maternal age [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/6809.html" rel="external">"Placenta previa: Management"</a> and  <a class="medical medical_review" href="/z/d/html/83129.html" rel="external">"Placenta accreta spectrum: Management", section on 'Cesarean hysterectomy'</a>.)</p><p>Even in the absence of abnormal placentation, cesarean delivery, as well as prior uterine surgery, appears to be a risk factor for peripartum hysterectomy [<a href="#rid3">3,23,24</a>]. In a population-based, case-control study, the risk of peripartum hysterectomy was lowest in women undergoing a first delivery that was vaginal (1 in 30,000) and highest in women with a history of two or more prior cesarean deliveries (1 in 220) [<a href="#rid25">25</a>]. In a study of 30,000 women undergoing cesarean delivery, the risk of peripartum hysterectomy was &lt;1 percent for the first, second, or third cesareans; 2 to 4 percent for the fourth and fifth procedures; and 9 percent after six or more cesareans [<a href="#rid23">23</a>]. While abnormal placentation contributes to hysterectomy risk with repeat cesareans, it is unclear whether the increased risk with primary cesarean delivery relates to the surgery itself, or reflects the indication for cesarean. Indications such as abruption, infection, macrosomia, or multiple gestations are risk factors themselves for hemorrhage and/or uterine atony. Alternatively, providers may move more quickly to hysterectomy for management of hemorrhage in patients whose abdomen is already open. (See  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage", section on 'Physiologic mechanisms that limit postpartum blood loss'</a> and  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage", section on 'Risk factors for PPH'</a>.)</p><p class="headingAnchor" id="H26335198"><span class="h2">Patient counseling</span><span class="headingEndMark"> — </span>Patients at risk for emergency peripartum hysterectomy should be counseled about the likelihood of the procedure and how the decision to proceed with hysterectomy will be made. Patients at risk and those with planned procedures should understand what the procedure involves, complications and outcomes of hysterectomy, and issues related to ovarian conservation. The patient should also be aware of the possible need for blood transfusion, mechanical ventilation, and recovery in an intensive care unit rather than a postpartum floor. </p><p class="headingAnchor" id="H26335219"><span class="h2">Scheduling delivery of patients at high risk for cesarean hysterectomy</span><span class="headingEndMark"> — </span>Patients at high risk of needing cesarean hysterectomy should be scheduled for delivery at a time when surgical staff and resources are immediately available, preferably avoiding an emergency delivery after the onset of labor. Surgical scheduling and consultations should be arranged with appropriate ancillary staff, which may include high-risk anesthesiologists, interventional radiologists, gynecologic oncologists, and urologists, depending on the complexity of the case. The primary surgeon should have significant experience with pelvic surgery and hysterectomy. Transfer of care to a tertiary care center may be necessary if these resources are not locally available [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H5515337"><span class="h2">Total versus supracervical hysterectomy</span><span class="headingEndMark"> — </span>In scheduled gynecologic surgery, there are no proven medical or surgical benefits of performing supracervical or subtotal hysterectomy if the cervix can be easily removed with the corpus . However in obstetric cases, supracervical hysterectomy may be preferable because removal of the cervix can be particularly challenging when the cervix is significantly dilated. In addition, supracervical hysterectomy may decrease total blood loss and operative time, which is important in the setting of severe acute hemorrhage. As a general guide, the cervix should be removed if cervical injury or bleeding is contributing to the hemorrhage, or if a previa/accreta may be invading the cervical stroma (often, this cannot be known with certainty until a pathologic analysis is performed). It is important to ensure that the entire placental bed has been removed in cases of placenta previa, which may require total hysterectomy or partial trachelectomy.</p><p>In a large study using data from the National Inpatient Sample, total hysterectomy was associated with more bladder and "other" (non-gastrointestinal, vascular, or ureteral) injuries, as well as more pulmonary complications and transfusion, but supracervical hysterectomy had higher rates of reoperation and perioperative death [<a href="#rid27">27</a>]. Although a retrospective cohort study reported no significant increase in complication rates when the cervix was removed after emergency cesarean delivery, surgical times were nearly identical with or without cervical removal, suggesting that the supracervical procedures may have been more complicated overall and that aborting cervical removal may have avoided excess morbidity [<a href="#rid28">28</a>]. A subsequent study focusing on peripartum hysterectomy reported higher rates of morbidity for total compared with supracervical approaches, although the study did not control for indication [<a href="#rid29">29</a>]. This study group recommended leaving the cervix if hemorrhage can be adequately controlled in this fashion.</p><p class="headingAnchor" id="H5515403"><span class="h2">Placement of hypogastric artery balloon catheters</span><span class="headingEndMark"> — </span>The author does not place preoperative arterial catheters routinely before planned puerperal hysterectomies, given little evidence of benefit and concern for complications; however, practice patterns vary among providers. In selected cases, intraoperative uterine artery embolization may be helpful, although the benefits of this procedure are less clear when hysterectomy is to be performed [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/83129.html" rel="external">"Placenta accreta spectrum: Management", section on 'Endovascular intervention for hemorrhage control'</a>.)</p><p>Preoperative placement of balloon catheters in the hypogastric arteries has been proposed as a means of decreasing total intraoperative blood loss in patients at risk for severe postpartum hemorrhage. The balloons are generally placed by interventional radiologists under fluoroscopic guidance immediately prior to surgery and inflated following delivery or in the event of hemorrhage.</p><p>A meta-analysis of both observational and randomly assigned trials found no significant benefit to internal iliac balloon catheters prior to deliveries with placenta accreta spectrum [<a href="#rid31">31</a>]. Most published studies are observational and subject to significant confounding by surgical and patient characteristics [<a href="#rid32">32-36</a>]. A relatively large retrospective study that controlled for confounding with both propensity score matching and logistic regression reported no difference in morbid outcomes with or without the balloons [<a href="#rid35">35</a>]. Similarly, two randomized trials comparing accreta management with and without the balloons reported no significant difference in morbidity [<a href="#rid37">37,38</a>].</p><p>Significant catheter-related complications have been described. In one series (19 patients), 2 patients developed arterial thrombosis and 1 had an internal iliac arterial dissection (16 percent complication rate) [<a href="#rid33">33</a>]. In another study (59 patients), 1 patient developed a thrombosis and 1 had a catheter-site hematoma (4 percent complication rate). A third series of 21 patients who received common iliac balloons reported that 2 (9.5 percent) required postoperative arterial thrombectomies [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H3897913684"><span class="h2">Placement of an aortic balloon catheter</span><span class="headingEndMark"> — </span>As the effectiveness of internal iliac balloon occlusion may be limited by collateral pelvic circulation, some centers use a balloon placed in the distal aorta. This location will occlude most of the pelvic circulation and can be placed under either fluoroscopic or ultrasound guidance. A meta-analysis comparing 463 aortic balloon recipients with 268 control women showed a significant reduction in blood transfusion volume, hysterectomy rate, operative duration, and length of hospital stay in the balloon group [<a href="#rid40">40</a>]. A different series comparing over 300 cases of retrograde endovascular balloon occlusion of the aorta with 128 controls also reported decreased volumes of hemorrhage and blood transfusion [<a href="#rid41">41</a>]. The balloons were almost always inflated for less than 40 minutes; the overall complication was 0.6 percent. Complications such as aortic tears and iliac thromboses have been described, and the procedure should be performed by radiologists or surgeons with specialized training [<a href="#rid42">42,43</a>].</p><p class="headingAnchor" id="H5515492"><span class="h2">Preoperative preparation</span><span class="headingEndMark"> — </span>Peripartum hysterectomy differs from hysterectomy in nonpregnant women in several important respects, most of which make the operation more difficult:</p><p class="bulletIndent1"><span class="glyph">●</span>The cervix may be quite soft and difficult to identify, especially if the patient has labored. In addition, the lower uterine segment may be highly developed and elongated, which may increase the risk of leaving endometrium behind with supracervical (subtotal) hysterectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blood vessels throughout the pelvis are greatly dilated, and varices are often found in the mesosalpinx and vesicouterine space, increasing the risk of massive hemorrhage, which may obscure the operative field.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The uterus is large and fills the pelvis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tissue, including the vaginal cuff and broad ligament, may be friable and prone to tearing when clamped.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The myometrium surrounding an invasive placenta (increta or percreta) may be very thin or absent, and placement of clamps on this tissue may lead to severe hemorrhage.</p><p></p><p>With these considerations in mind, the author makes the following preparations in patients at high risk of undergoing hysterectomy to prevent or control massive hemorrhage:</p><p class="bulletIndent1"><span class="glyph">●</span>Notify the anesthesia team in advance so anesthesia staff experienced with anesthetic management of massive hemorrhage and transfusion conduct the case. While epidural or combined spinal/epidural anesthesia is possible, general anesthesia should be immediately available [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assign surgical assistants familiar with hysterectomy, as well as experienced nursing staff and surgical technicians, or ensure that these personnel are readily available for staffing the case.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ensure adequate intravenous access with multiple large-bore lines, and possibly an arterial line, before surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Administer prophylactic antibiotics within one hour of skin incision to decrease the risk of postoperative infection  (<a class="graphic graphic_table graphicRef87200" href="/z/d/graphic/87200.html" rel="external">table 3</a>). Intraoperative re-dosing is needed if blood loss exceeds 1500 mL or operative time exceeds four hours.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cross-match both packed red blood cells and plasma. In patients suspected of accreta, we have four units of both products immediately available and ask the blood bank to keep this amount available at all times as the products are transfused. For patients at lower risk for massive bleeding (such as those with large leiomyomas or prior classical cesarean delivery, myomectomy, severe adhesions, or placenta previa without prior cesarean delivery), the author has two units of blood immediately available, with more available for crossmatch, as needed. The blood bank should ensure the availability of cryoprecipitate and platelets, if required, and the facility should have a massive transfusion protocol in place. All centers that may provide peripartum hysterectomy should have a massive transfusion protocol in place and should perform periodic drills to simulate massive blood replacement [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Confirm that appropriate instrumentation is available:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Self-retaining retractor designed to give adequate lateral exposure (eg, Bookwalter or disposable self-retaining retractor)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sufficient number of pedicle clamps adequate to hold tissue without tearing or slippage (eg, Heaney, Rogers, or Zeppelin clamps)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Electro-dissection unit</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two suction devices</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adequate number and types of sutures, including absorbable synthetic sutures of various sizes and delayed absorbable suture for a vertical fascial incision</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disposable bipolar electrosurgical device (eg, LigaSure) can be very helpful to control back bleeding and manage hypervascularity during the dissection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Atraumatic hemostatic clamps, such as ring or lung clamps</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Place a bladder catheter to drain urine and facilitate instillation of fluid to test bladder integrity, if required intraoperatively. Ureteral stents can be placed preoperatively, if the patient has an accreta or major adhesions with the need for parametrial dissection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Place a device for intermittent pneumatic compression to reduce the risk of deep vein thrombosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Place the patient in lithotomy position using a boot-type stirrup, if possible, as this allows better assessment of intraoperative vaginal blood loss and allows ready access to the bladder or vagina from below. We advise placing a conical collection bag under the patient's buttocks, preferably with graduated markings to aid in blood loss quantification. Unscrubbed members of the operating room team should be assigned to quantify vaginal blood loss periodically. A scale may also be brought into the operating room for gravimetric blood loss assessment of soaked laparotomy sponges.</p><p></p><p class="bulletIndent1">Prep the vagina with povidone-iodine. Before a planned total hysterectomy, some surgeons tag the external os with sutures (if no previa) or place a tagged (counted) sponge just beneath the cervix to aid intraoperative identification. Others have described placing a sponge stick or an end-to-end anastomosis sizer into the vagina, then directing it into the vaginal fornices intraoperatively to identify the upper vagina [<a href="#rid45">45,46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have patient- and fluid-warming devices available to avoid hypothermia, which should be anticipated in shock or massive transfusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If available, consider using intraoperative cell salvage and autotransfusion of red blood cells. The procedure has been performed safely in hundreds of obstetric patients and appears to be cost-effective in the setting of anticipated gravid hysterectomy [<a href="#rid47">47-49</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">OPERATIVE PROCEDURE</span></p><p class="headingAnchor" id="H608458"><span class="h2">Key points</span><span class="headingEndMark"> — </span>This synopsis illustrates the key points of the more comprehensive discussion of the operative procedure that follows:</p><p class="bulletIndent1"><span class="glyph">●</span>In the setting of significant hemorrhage or an unstable patient, clamping or compressing the uterine blood supply takes precedence over adhesiolysis and retractor placement. Pedicles can be rapidly clamped and cut, and sutured later. When severe hemorrhage prohibits adequate visualization of the pelvis, the aorta can be compressed manually over the sacrum and the pelvis carefully packed until the bleeding slows. A trauma surgeon may be consulted, if available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the patient is hemodynamically stable, obtaining adequate exposure and uterine traction will minimize vascular or ureteral injury.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the bladder does not reflect readily off the cervix, it may be opened at the dome. Palpation and inspection of the posterior bladder from the interior makes it easier to find the dissection plane between these two organs. In addition, the cervix may be fused to the bladder (especially in placental percreta), thus requiring resection of a portion of the bladder. Consultation with a gynecologic oncologist or urologist is warranted if the surgeon does not have sufficient experience with bladder surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Every attempt should be made to identify the ureter and avoid ligating it. However, control of hemostasis is more important than preserving the ureter intact. Ligation of one or both ureters can be reversed in a subsequent operation after hemostasis has been achieved and coagulopathy and hypovolemia have been corrected.</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Incision and delivery</span><span class="headingEndMark"> — </span>The author prefers a vertical skin incision to help ensure adequate exposure, specifically in cases of placenta accreta spectrum involving a prior low transverse hysterotomy. A Pfannenstiel incision may be appropriate in selected cases with an unscarred uterus or no placenta previa, and when exposure is expected to be adequate. If a transverse skin incision is performed, it should be as wide as possible, and the surgeon should be prepared to divide the rectus muscles (Maylard incision) or perform a Cherney approach if the incision does not provide adequate exposure.</p><p>A low transverse hysterotomy is acceptable if it is not over the placenta and can be made without causing excessive bleeding. Avoiding disruption of a known abnormally implanted anterior placenta or transection of large anterior fibroids is essential and is best accomplished through a classical (fundal) uterine incision. A high hysterotomy may also be preferable in the setting of large bladder varicosities or significant anterior adhesions. The hysterotomy can be made hemostatic rapidly using atraumatic hemostatic clamps or a single running layer with sturdy suture (eg, loop #1 polydioxanone [eg, PDS]) on a large needle.</p><p>With a fundal hysterotomy, a fetus in vertex or transverse lie is most easily delivered as a breech. Following delivery of the fetus, the placenta should be removed, if nonadherent, to allow maximal uterine contraction. <a class="drug drug_general" data-topicid="9734" href="/z/d/drug information/9734.html" rel="external">Oxytocin</a> is then given to maintain uterine tone until the blood supply is disconnected. Any adherent placenta should be left in place as removal can increase total blood loss [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/z/d/html/83129.html" rel="external">"Placenta accreta spectrum: Management", section on 'Cesarean hysterectomy'</a>.)</p><p>After delivery, placing the patient in Trendelenburg position, use of a self-retaining retractor, and packing the abdominal contents can facilitate visualization [<a href="#rid51">51</a>]. In addition, insertion of an intrauterine balloon or intrauterine packing for tamponade slows severe bleeding. The balloon or pack should be removed during the hysterectomy as bleeding is controlled surgically because lateral bulging may impede uterine artery and cardinal ligament dissection. (See  <a class="medical medical_review" href="/z/d/html/4440.html" rel="external">"Postpartum hemorrhage: Use of an intrauterine hemorrhage-control device"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Hysterectomy</span><span class="headingEndMark"> — </span>The technique should be simple enough to perform rapidly and should minimize the creation of dead space and raw surfaces because of the possibility of coexistent coagulopathy. When hemorrhage is severe, control of the uterine blood supply takes precedence over surgical dissection, and, in a hemodynamically unstable patient, this may require risking urinary tract, adnexal, or bowel injury.</p><p>The procedure is begun by using electro-dissection to lyse adhesions to the uterus. When the uterus is free, the fundus is extracorporealized, and an assistant maintains traction on the fundus until the uterus is removed. If the adhesions are highly vascular, early control of the uterine blood supply by dissecting and ligating the uterine arteries at their lateral edges may be preferable. This is particularly true with an anterior placenta accreta, as dissection of the vesicouterine space may lead to significant hemorrhage.</p><p>Each round ligament is doubly clamped laterally with curved clamps whose concave surface is directed medially. The tissue between the clamps is divided using Mayo scissors or electro-dissection, and each clamp is replaced with a suture ligature. The broad ligament is then opened, and the adnexal pedicles are isolated. The ovaries are almost always left in place, unless a severely adherent ovary necessitates a lengthy dissection during a hemorrhagic emergency. The fallopian tube and utero-ovarian ligament are then isolated and clamped. Placing clamps directly on the uterus may be inadvisable in the setting of hypertrophic vessels. In this circumstance, identifying and opening a clear space below each vascular bundle should be attempted. Each pedicle is then clamped with a vascular clamp, transected, and suture ligated. This should be done in a single bundle, if possible, but may require multiple pedicles on each side if the bundle is too large to ligate safely. In the presence of severe hemorrhage, however, the operation can be performed more rapidly if the pedicles are not sutured until all of the vascular structures to the uterine arteries have been clamped and divided. This requires a sufficient number of clamps to be available. Use of a bipolar ligature device, such as the LigaSure instrument, allows the procedure to be performed more rapidly, but we still prefer to secure the proximal pedicles with sutures after the blood supply has been controlled.</p><p>The posterior leaf of the broad ligament is then opened towards the cervix, dropping the ureters inferiorly and clearing the endopelvic fascia posterior to the uterine vessels. The uterine vessels are then skeletonized by carefully opening overlying tissue with cautery. If cesarean delivery was performed, the bladder flap may have been developed. Otherwise, the bladder may be released by gently spreading the tips of Metzenbaum scissors or a tonsil clamp in the vesicouterine peritoneum and using electro-dissection to transect the serosa. The vesicocervical space is developed and bladder pillars divided, but no further distally than will be necessary to allow exposure and clamping of the uterine vessels. Large varicosities in the vesicouterine space, as can be seen with placenta previa or accreta, may require bipolar coagulation or clamping with suture ligation. Gentle finger dissection may speed the procedure once good planes have been created, but blunt dissection with a sponge stick is inadvisable as massive bleeding or bladder laceration may result. If scarring has obliterated the vesicocervical space (as can occur after previous cesarean deliveries), sharp dissection with Metzenbaum scissors may be necessary to perform this dissection.</p><p>If a difficult or highly vascular dissection is anticipated, then it may be prudent to secure the uterine blood supply prior to completing the midline bladder dissection. This may be accomplished by opening the paravesical spaces and clearing the endopelvic fascia just medial to the ascending uterine vessels. This allows the arteries to be safely clamped and sutured with bladder adhesions undisturbed. These bladder adhesions can then be taken down sharply or with cautery after the majority of the uterine blood supply has been controlled. When there is concern for placental bladder invasion, a posterior approach to the dissection may be considered [<a href="#rid45">45</a>]. This involves opening the posterior vagina through the pouch of Douglas, then securing the uterosacral and cardinal ligaments and uterine arteries prior to developing the bladder plane from below. </p><p>The ureters are identified by visualizing them through the peritoneum of the posterior broad ligament, or by palpation when stented. If their position is in doubt, then the retroperitoneum should be opened further and the ureter directly visualized. Their position should be confirmed frequently during the procedure. </p><p>The uterine arteries may then be exposed by carefully dissecting the broad ligament. This often requires clamping or coagulating vessels within the ligament. Sequentially clamping and transecting the ascending uterine arteries, against the lateral uterus, may be most expedient, with the final pedicle containing the uterine vessels. However, caution should be used with a retained placenta accreta or percreta, in which case clamping of the vascular uterine tissue can lead to massive hemorrhage. In this circumstance, the uterine arteries should be dissected and identified lateral to the uterus, and clamped at their insertion. This requires identification of the ureters either visually or by palpation (in the case of stenting) as the arteries are clamped. At least one retrospective study has shown that preoperative ureteral stenting was associated with a significant reduction in early postoperative morbidity, possibly by facilitating the identification of the ureters or ureteral injury [<a href="#rid50">50</a>].</p><p>Once the major vessels have been ligated and the bladder has been displaced inferiorly, each cardinal ligament is divided in several bites by clamping close to the cervix with a straight clamp, dividing the tissue medially with scissors or a scalpel, and suturing the pedicle. After dissecting the upper cardinal ligaments, a supracervical hysterectomy can be performed by clamping the lateral cervical vessels and transecting the mid cervix with scissors or electrosurgery. After ligating the lateral vascular pedicles, the cervical edges are oversewn with figure-of-eight or running sutures. In the setting of a placenta previa, the excised boundary of the cervix should be examined to ensure that a cuff of clear endocervix lies beneath the placental bed.</p><p>Alternatively, if the cervix is to be completely removed, the cul-de-sac is examined to ensure that the rectal reflection is not abnormally high. The bladder is further reflected off the entire cervix and the proximal vagina. The cardinal ligaments are clamped and transected with incorporation of the lateral cervical vessels until the base of the cervix is reached. If the distal cervix is difficult to identify, the cervix may be transected above the level of vessel dissection and the uterine specimen removed. The external cervical os can then be palpated through this incision and used to define the distal limit of cardinal ligament dissection. The vaginal angle and uterosacral ligament on each side are clamped into a bundle with a curved clamp. The vagina is then severed with scissors medial to each clamp. Following this, each clamp is replaced with a suture ligature. The remainder of the vaginal cuff is closed with a running suture. Incorporating the peritoneum posteriorly may aid hemostasis. The suture should include approximately 10 mm of the upper vaginal cuff to avoid later bleeding or breakdown; in this process, it is important to avoid the bladder anteriorly.</p><p class="headingAnchor" id="H1080098064"><span class="h3">Special considerations with placenta accreta spectrum</span><span class="headingEndMark"> — </span>Due to hypervascularity of the lower uterine segment and high potential for placental disruption, more radical approaches have been described for cases of severe accreta spectrum (such as percreta) [<a href="#rid45">45,52</a>]. The author strongly advises the involvement of an experienced pelvic surgeon or gynecologic oncologist when managing these cases. If placenta percreta is unexpectedly encountered at the time of delivery, the obstetrician should consider aborting the procedure if possible or delivering the neonate through the uterine fundus and then closing the fundal incision without any placental disruption. The patient should then be carefully monitored in the operating room until surgical help or patient transfer can be arranged.</p><p class="headingAnchor" id="H8"><span class="h3">Evaluation of bladder and ureteral integrity</span><span class="headingEndMark"> — </span>Integrity of the bladder can be confirmed by infusing 200 mL of <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> mixed with two or three drops of <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">methylene blue</a> through the bladder catheter; extravasation of blue fluid signifies a leak. The ureters are inspected to determine that they are intact, peristalsing, and of normal caliber. If there is concern for ureteral injury, this may be tested by injecting one to two ampules (5 mL per ampule) of <a class="drug drug_general" data-topicid="9088" href="/z/d/drug information/9088.html" rel="external">indigo carmine</a> intravenously; blue urine will spill into the pelvis in 10 to 15 minutes if a ureter has been cut. This method is, however, unlikely to reveal ligation of the ureter. Cystoscopy or direct visualization of the ureters through a cystotomy (the latter requiring urine dye) demonstrate urine passing through both ureteral orifices. Absence of this finding suggests that one or both ureters are obstructed as a result of surgery. A ureteral stent can be passed through the ureteral orifice to localize the site of obstruction. (See  <a class="medical medical_review" href="/z/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management"</a>.)</p><p>If a cystotomy has been created inadvertently or intentionally, it should be closed with two layers of absorbable synthetic suture. If the injury occurs at the level of the bladder trigone, stenting may be necessary, and urologic consultation is recommended. (See  <a class="medical medical_review" href="/z/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management"</a>.)</p><p class="headingAnchor" id="H5515605"><span class="h3">Inspection and closure</span><span class="headingEndMark"> — </span>The pelvis should be copiously irrigated and suctioned, and blood-soaked packs should be removed. Each vascular pedicle should be checked for hemostasis, as should the dissection sites. The abdomen is closed using any standard technique, after ensuring good hemostasis. No drains are necessary, unless there is concern for ongoing bleeding or persistent bladder leak.</p><p class="headingAnchor" id="H10"><span class="h1">PERSISTENT PELVIC BLEEDING</span><span class="headingEndMark"> — </span>Bleeding in the deep pelvis may persist following hysterectomy. </p><p class="headingAnchor" id="H3415958088"><span class="h2">Assess for coagulopathy</span><span class="headingEndMark"> — </span>Ideally, coagulation is assessed with laboratory testing and, if abnormal, managed with transfusion of blood products, patient warming, and correction of acidemia and hypocalcemia. (See  <a class="medical medical_review" href="/z/d/html/15147.html" rel="external">"Etiology and diagnosis of coagulopathy in trauma patients"</a>.)</p><p>Intraoperative testing options include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Direct observation of blood specimen</strong> – Prior to the return of the first set of laboratory studies, a red top tube of 5 mL blood can be observed for clotting. If the blood in the tube clots within 8 to 10 minutes and the clot remains intact, the patient likely has adequate fibrinogen stores. If the blood in the tube does not clot or an initial clot dissolves, it is likely that the patient is markedly deficient in key clotting factors.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Viscoelastic testing</strong> – Some centers use point-of-care viscoelastic testing (POCVT) for more rapid coagulation testing and guidance on blood product replacement. One small trial reported decreased use of blood products when the POCVT-directed transfusion protocol was followed, but the difference was not significantly different in the intention-to-treat analysis [<a href="#rid53">53</a>]. A review of retrospective studies reported that POCVT may be linked to lower transfusion rates with postpartum hemorrhage, but larger well-controlled studies are needed to determine the utility and cost effectiveness of these methods [<a href="#rid54">54</a>]. </p><p></p><p class="bulletIndent1">Discussions of viscoelastic testing with thromboelastoplasty (TEG) and rotational thromboelastography (ROTEM) are presented in detail separately. (See  <a class="medical medical_review" href="/z/d/html/4433.html" rel="external">"Platelet function testing", section on 'Viscoelastic testing (TEG and ROTEM)'</a>.)</p><p></p><p class="headingAnchor" id="H1071397477"><span class="h2">Surgical techniques</span><span class="headingEndMark"> — </span>Surgical hemostasis may be achieved by placing running and figure-of-eight absorbable sutures in bleeding areas or with the direct application of cautery. If this does not control bleeding, hemostatic agents  (<a class="graphic graphic_table graphicRef71852" href="/z/d/graphic/71852.html" rel="external">table 4</a>) and pelvic packing are the next steps. (See  <a class="medical medical_review" href="/z/d/html/3302.html" rel="external">"Management of hemorrhage in gynecologic surgery", section on 'Prolonged pelvic packing'</a> and <a class="local">'Pelvic packing'</a> below.)</p><p class="headingAnchor" id="H11"><span class="h2">Hemostatic agents</span><span class="headingEndMark"> — </span>Small areas of low-volume bleeding can be treated with topical hemostatic agents [<a href="#rid55">55,56</a>]. Investigation of these agents has focused on vascular, cardiac, and hepatic surgery [<a href="#rid57">57,58</a>]. There are few high-quality data regarding treatment efficacy or use in obstetric and gynecologic surgery. Thus, choices are made based on surgeon preference, availability, and cost effectiveness  (<a class="graphic graphic_table graphicRef71852" href="/z/d/graphic/71852.html" rel="external">table 4</a>). (See  <a class="medical medical_review" href="/z/d/html/3302.html" rel="external">"Management of hemorrhage in gynecologic surgery", section on 'Topical hemostatic agents'</a>.)</p><p>These agents should not be used for intravascular injection, in closure of skin incisions, or for treatment of bleeding from the endometrium. They also should not be used in infected tissue. If red blood cell salvage is being performed, it should be stopped as soon as hemostatic agents are placed in the pelvis and should not be resumed.</p><p class="headingAnchor" id="H13"><span class="h2">Pelvic packing</span><span class="headingEndMark"> — </span>Packing is a last resort that usually succeeds in controlling low-pressure (microvascular or venous) bleeding confined to the pelvis [<a href="#rid59">59</a>]. There are multiple variations of this procedure; selection is based on surgeon preference and available materials. One approach is to tie Kerlix bandages together end-to-end to form one long strip for packing. If Kerlix is not available, dry laparotomy sponges may be used. The dry sponges are packed gently but firmly into the pelvis so that the pack fills all interstices, but does not abrade pelvic tissue. If the packing is successful, no blood will be seen seeping through or around the gauze after 10 minutes of observation. Alternate options include using gauze stuffed into an x-ray cassette drape, an inflated uterine balloon brought out through the vagina  (<a class="graphic graphic_picture graphicRef93394" href="/z/d/graphic/93394.html" rel="external">picture 1</a>), or an umbrella pack [<a href="#rid60">60-69</a>].</p><p>Most often, a temporary abdominal closure will be placed over the packings, possibly with the addition of a negative pressure wound system to remove fluids and avoid an abdominal compartment syndrome (see  <a class="medical medical_review" href="/z/d/html/15145.html" rel="external">"Management of the open abdomen in adults"</a>)</p><p>These patients usually require intensive care unit admission to manage coagulopathy, ventilation, hypothermia, and metabolic abnormalities. (See  <a class="medical medical_review" href="/z/d/html/3302.html" rel="external">"Management of hemorrhage in gynecologic surgery"</a>.)</p><p>Laparotomy is usually needed to remove the pack, or it may be removed through the vagina or another conduit. Postoperative fever is common, and broad-spectrum antibiotics are given until the packing is removed. Removal should take place under general anesthesia 36 to 72 hours after insertion. Bleeding may resume if the pack is removed too early or in the presence of coagulopathy, whereas pelvic infection is likely if removal is delayed [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H15"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>The principal complications after peripartum hysterectomy are febrile morbidity, hemorrhage, urinary tract injury, coagulopathy, paralytic ileus or bowel obstruction, and reoperation. Emergency procedures are associated with a higher rate of complications than planned procedures [<a href="#rid71">71</a>]. Mortality should be &lt;1 percent, though a global summary of emergency cases reported mortality rates ranging from 0 to 59 percent, with a composite rate of 5.2 percent [<a href="#rid5">5,72</a>]. The findings from several large series of peripartum hysterectomy are illustrated below:</p><p class="bulletIndent1"><span class="glyph">●</span>A prospective series by the Maternal-Fetal Medicine Units (MFMU) Network included 186 cesarean hysterectomies performed in 1999 and 2000 and reported the following complications and their frequencies: red blood cell transfusion (84 percent), transfusion of other blood products (34 percent), fever (11 percent), ileus (5 percent), exploratory laparotomy (4 percent), hospital readmission (4 percent), urinary tract infection (3 percent), cuff abscess (2.7 percent), maternal death (1.6 percent), bowel injury (1 percent), wound dehiscence (1 percent), pelvic or deep vein thrombosis (1 percent) [<a href="#rid73">73</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data from the Nationwide Inpatient Sample (a random sample of 20 percent of hospital discharges in the United States) from 1998 to 2007 showed the following types and rates of complications in 4967 peripartum hysterectomies: transfusion (46 percent), infection (12 percent), wound complication (10 percent), bladder injury (9 percent), reoperation (4 percent), venous thromboembolism (1 percent); and intestinal, ureteral, or vascular injury (≤1 percent) [<a href="#rid27">27</a>]. Transfusion, infection, urinary tract injury, and reoperation were much more frequent than in nonobstetric hysterectomy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A review of six studies of peripartum hysterectomy reported the following ranges of complications: febrile morbidity (11 to 34 percent), cystotomy (6 to 29 percent), ureteral injury (2 to 7 percent), oophorectomy (6 percent), reoperation (4 to 33 percent), thromboembolism (1 to 4 percent), death (0 to 4.2 percent) [<a href="#rid51">51</a>].</p><p></p><p class="headingAnchor" id="H16"><span class="h1">POSTOPERATIVE CARE</span><span class="headingEndMark"> — </span>Routine posthysterectomy and postpartum care is appropriate if the patient is stable. Patient-controlled analgesia (either intravenous or epidural) is preferable until she can take oral medicine. Wound care is conducted according to the surgeon's preference.</p><p>Enhanced Recovery after Surgery (ERAS) protocols are used for anticipated peripartum hysterectomy cases at the author's hospital in the same manner as for other scheduled cesareans [<a href="#rid74">74</a>]. Protocols can be modified based on an individual's postoperative status, but early oral intake and ambulation are encouraged when possible. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation"</a>.). </p><p class="headingAnchor" id="H161174"><span class="h2">Prophylaxis</span><span class="headingEndMark"> — </span>If the operation was clean contaminated, no postoperative antibiotics are indicated. Active infection should be treated appropriately. (See  <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">"Antimicrobial prophylaxis for prevention of surgical site infection in adults"</a>.)</p><p>Women undergoing peripartum hysterectomy are at moderate risk or high risk of postoperative thromboembolic disease, depending on individual risk factors; therefore, both mechanical and pharmacologic prophylaxis for deep venous thrombosis are suggested. Pharmacologic prophylaxis is initiated at least four hours postoperatively; timing depends on patient-specific factors in the balance between risk of bleeding and risk of venous thrombosis, and whether a neuraxial catheter is left in place after surgery is completed. Prophylaxis is discontinued when the patient is discharged, but may be prolonged in selected women at highest risk of venous thromboembolism, such as those who have had a previous thromboembolic event.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1347.html" rel="external">"Venous thromboembolism in pregnancy: Prevention", section on 'Cesarean section'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">"Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"</a>.)</p><p></p><p class="headingAnchor" id="H161210"><span class="h2">Bladder care</span><span class="headingEndMark"> — </span>If urinary stents were placed, they can be removed immediately postoperatively. The bladder catheter can also be removed within 24 hours postoperatively in stable patients who do not require monitoring hourly urinary output. However, if a cystotomy was repaired, then drainage is generally continued for 5 to 10 days. A large repair (&gt;2 cm) should be evaluated with a cystourethrogram prior to discontinuing the catheter. (See  <a class="medical medical_review" href="/z/d/html/3276.html" rel="external">"Urinary tract injury in gynecologic surgery: Identification and management"</a>.)</p><p class="headingAnchor" id="H161228"><span class="h2">Diet</span><span class="headingEndMark"> — </span>Clear liquids are ordered after surgery, and the diet is advanced with patient appetite and tolerance of oral intake. Nausea, anorexia, abdominal distention, or vomiting are signs of paralytic ileus. Mild symptoms can be managed with restriction of oral intake and intravenous fluids, while more severe vomiting should be evaluated radiographically. Confirmed ileus or partial obstruction should be treated with nasogastric suction with intravenous fluid and electrolyte repletion. (See  <a class="medical medical_review" href="/z/d/html/8042.html" rel="external">"Postoperative ileus"</a>.)</p><p class="headingAnchor" id="H161247"><span class="h2">Breastfeeding</span><span class="headingEndMark"> — </span>Hemorrhage and hysterectomy are not contraindications to breastfeeding. Patients admitted to the intensive care unit may use a breast pump once they are extubated and stabilized. Early pumping is encouraged when the newborn is admitted to the neonatal intensive care unit. Breast milk output should be considered in the patient's fluid management, although this is usually not a concern by the time her milk supply develops. In the setting of a physically or psychologically difficult recovery, patients who are unwilling or unable to breastfeed should be supported.</p><p>Sheehan syndrome should be considered in women who fail to lactate postpartum or develop other manifestations of hypopituitarism. (See  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage", section on 'Long-term morbidity'</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing of hysterectomy</strong> – Timing is critical to an optimal outcome: hysterectomy should not be performed too early or too late. There is a relationship between the duration of time that passes prior to deciding to perform an emergency hysterectomy, the amount of blood loss, and the likelihood that the hysterectomy will be seriously complicated by coagulopathy, severe hypovolemia, tissue hypoxia, hypothermia, and acidosis, which further compromise the patient's status. (See <a class="local">'Surgical planning'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical planning</strong> – Anticipating the possible need for peripartum hysterectomy based on the patient's risk factors enables patient preparation and counseling in the antenatal period, detailed surgical planning, and possibly avoidance of an emergency procedure. (See <a class="local">'Preoperative risk assessment'</a> above and <a class="local">'Scheduling delivery of patients at high risk for cesarean hysterectomy'</a> above and <a class="local">'Preoperative preparation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Operative planning</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vertical skin incision</strong> – A vertical skin incision is generally required for sufficient exposure. A Pfannenstiel incision may be acceptable in thin patients with no previa or large fibroids and at very low risk of having adhesions. A Pfannenstiel incision may also be appropriate when the placenta has previously been delivered, such as in cases of intractable uterine atony. (See <a class="local">'Incision and delivery'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adherent placenta</strong> – In the case of suspected placenta previa/accreta, the surgeon should take care to not disrupt the adherent placenta, which usually requires a fundal hysterotomy. (See <a class="local">'Hysterectomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Supracervical hysterectomy</strong> – Supracervical hysterectomy is a reasonable option unless there is specific indication for removal of the cervix. (See <a class="local">'Total versus supracervical hysterectomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Limited role of arterial balloon catheters</strong> – The author does not place preoperative arterial balloon catheters routinely before planned puerperal hysterectomies, given little evidence of benefit and concern for complications. (See <a class="local">'Placement of hypogastric artery balloon catheters'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Key surgical points</strong> – Key points of the operative procedure include (see <a class="local">'Key points'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In emergency hemorrhage or an unstable patient, clamping the uterine blood supply takes precedence over adhesiolysis and packing. Pedicles can be rapidly clamped and cut, and sutured later.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When the patient is hemodynamically stable, obtaining adequate exposure and uterine traction will minimize vascular or ureteral injury.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>It may be difficult to determine the boundary between the cervix and vagina as a dilated cervix is effaced and soft. Placing sutures, clips, or a ring forceps to "tag" the cervix reduces this problem. Before a planned total hysterectomy, the external os may be tagged with sutures (if no previa) or a tagged (counted) sponge, sponge stick, or end-to-end anastomosis sizer may be placed vaginally to aid intraoperative cervical and vaginal identification.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the bladder does not reflect readily off the cervix, it should be opened at the dome. Palpation and inspection of the posterior bladder from the interior makes it easier to find the dissection plane between these two organs. In addition, the cervix may be fused to the bladder (especially in placental percreta), thus requiring resection of a portion of the bladder. Consultation with a gynecologic oncologist or urologist is warranted if the surgeon does not have sufficient experience with bladder surgery.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Every attempt should be made to identify the ureter and avoid ligating it. However, control of hemostasis is more important than preserving the ureter intact. Ligation of one or both ureters can be reversed in a subsequent operation after hemostasis has been achieved and coagulopathy and hypovolemia have been corrected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Plan for transfusion needs</strong> – Preparation should be made for massive transfusion and avoidance of coagulopathy. When bleeding cannot be stopped surgically, pelvic packing, temporary closure, and transfer to an intensive care unit may be necessary. This should usually proceed with the assistance of a general or trauma surgeon. (See <a class="local">'Preoperative preparation'</a> above and <a class="local">'Persistent pelvic bleeding'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – The principal complications of peripartum hysterectomy are hemorrhage, urinary tract injury, coagulopathy, and infection. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="headingAnchor" id="H2202432"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. Allan J Jacobs, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Govindappagari S, Wright JD, Ananth CV, et al. Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume. Obstet Gynecol 2016; 128:1215.</a></li><li><a class="nounderline abstract_t">Kallianidis AF, Rijntjes D, Brobbel C, et al. Incidence, Indications, Risk Factors, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis. Obstet Gynecol 2023; 141:35.</a></li><li><a class="nounderline abstract_t">Whiteman MK, Kuklina E, Hillis SD, et al. Incidence and determinants of peripartum hysterectomy. Obstet Gynecol 2006; 108:1486.</a></li><li><a class="nounderline abstract_t">Imudia AN, Awonuga AO, Dbouk T, et al. Incidence, trends, risk factors, indications for, and complications associated with cesarean hysterectomy: a 17-year experience from a single institution. Arch Gynecol Obstet 2009; 280:619.</a></li><li><a class="nounderline abstract_t">Jakobsson M, Tapper AM, Colmorn LB, et al. Emergency peripartum hysterectomy: results from the prospective Nordic Obstetric Surveillance Study (NOSS). Acta Obstet Gynecol Scand 2015; 94:745.</a></li><li><a class="nounderline abstract_t">Campbell SM, Corcoran P, Manning E, et al. Peripartum hysterectomy incidence, risk factors and clinical characteristics in Ireland. Eur J Obstet Gynecol Reprod Biol 2016; 207:56.</a></li><li><a class="nounderline abstract_t">Friedman AM, Wright JD, Ananth CV, et al. Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations. Am J Obstet Gynecol 2016; 215:640.e1.</a></li><li><a class="nounderline abstract_t">Cromi A, Candeloro I, Marconi N, et al. Risk of peripartum hysterectomy in births after assisted reproductive technology. Fertil Steril 2016; 106:623.</a></li><li><a class="nounderline abstract_t">Maraschini A, Lega I, D'Aloja P, et al. Women undergoing peripartum hysterectomy due to obstetric hemorrhage: A prospective population-based study. Acta Obstet Gynecol Scand 2020; 99:274.</a></li><li><a class="nounderline abstract_t">Huque S, Roberts I, Fawole B, et al. Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial. BMC Pregnancy Childbirth 2018; 18:186.</a></li><li><a class="nounderline abstract_t">Glaze S, Ekwalanga P, Roberts G, et al. Peripartum hysterectomy: 1999 to 2006. Obstet Gynecol 2008; 111:732.</a></li><li><a class="nounderline abstract_t">Bodelon C, Bernabe-Ortiz A, Schiff MA, Reed SD. Factors associated with peripartum hysterectomy. Obstet Gynecol 2009; 114:115.</a></li><li><a class="nounderline abstract_t">Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010; 115:637.</a></li><li><a class="nounderline abstract_t">Flood KM, Said S, Geary M, et al. Changing trends in peripartum hysterectomy over the last 4 decades. Am J Obstet Gynecol 2009; 200:632.e1.</a></li><li><a class="nounderline abstract_t">Colmorn LB, Krebs L, Langhoff-Roos J, NOSS study group. Potentially Avoidable Peripartum Hysterectomies in Denmark: A Population Based Clinical Audit. PLoS One 2016; 11:e0161302.</a></li><li><a class="nounderline abstract_t">Hernandez JS, Nuangchamnong N, Ziadie M, et al. Placental and uterine pathology in women undergoing peripartum hysterectomy. Obstet Gynecol 2012; 119:1137.</a></li><li><a class="nounderline abstract_t">Bigelow CA, Horowitz NS, Goodman A, et al. Management and outcome of cervical cancer diagnosed in pregnancy. Am J Obstet Gynecol 2017; 216:276.e1.</a></li><li><a class="nounderline abstract_t">Main EK, Goffman D, Scavone BM, et al. National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage. Obstet Gynecol 2015; 126:155.</a></li><li><a class="nounderline abstract_t">Knight M, UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007; 114:1380.</a></li><li><a class="nounderline abstract_t">Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG 2014; 121:62.</a></li><li><a class="nounderline abstract_t">Giambattista E, Ossola MW, Duiella SF, et al. Predicting factors for emergency peripartum hysterectomy in women with placenta previa. Arch Gynecol Obstet 2012; 285:901.</a></li><li><a class="nounderline abstract_t">Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177:210.</a></li><li><a class="nounderline abstract_t">Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107:1226.</a></li><li><a class="nounderline abstract_t">Kallianidis AF, Maraschini A, Danis J, et al. Epidemiological analysis of peripartum hysterectomy across nine European countries. Acta Obstet Gynecol Scand 2020; 99:1364.</a></li><li><a class="nounderline abstract_t">Knight M, Kurinczuk JJ, Spark P, et al. Cesarean delivery and peripartum hysterectomy. Obstet Gynecol 2008; 111:97.</a></li><li><a class="nounderline abstract_t">Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117:331.</a></li><li><a class="nounderline abstract_t">Wright JD, Devine P, Shah M, et al. Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol 2010; 115:1187.</a></li><li><a class="nounderline abstract_t">Imudia AN, Hobson DT, Awonuga AO, et al. Determinants and complications of emergent cesarean hysterectomy: supracervical vs total hysterectomy. Am J Obstet Gynecol 2010; 203:221.e1.</a></li><li><a class="nounderline abstract_t">Bulbul M, Karacor T, Peker N, et al. The effect of surgical procedure on surgical outcomes in patients undergoing emergency peripartum hysterectomy: a retrospective multicenter study. J Matern Fetal Neonatal Med 2022; 35:5768.</a></li><li><a class="nounderline abstract_t">Pan Y, Zhou X, Yang Z, et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. Int J Gynaecol Obstet 2017; 137:45.</a></li><li><a class="nounderline abstract_t">Liang D, Zhao H, Liu D, Lin Y. Internal iliac artery balloon occlusion in the management of placenta accreta: A systematic review and meta-analysis. Eur J Radiol 2021; 139:109711.</a></li><li><a class="nounderline abstract_t">Tan CH, Tay KH, Sheah K, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol 2007; 189:1158.</a></li><li><a class="nounderline abstract_t">Shrivastava V, Nageotte M, Major C, et al. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007; 197:402.e1.</a></li><li><a class="nounderline abstract_t">Ballas J, Hull AD, Saenz C, et al. Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox. Am J Obstet Gynecol 2012; 207:216.e1.</a></li><li><a class="nounderline abstract_t">Chen M, Lv B, He G, Liu X. Internal iliac artery balloon occlusion during cesarean hysterectomy in women with placenta previa accreta. Int J Gynaecol Obstet 2019; 145:110.</a></li><li><a class="nounderline abstract_t">Lee AY, Ballah D, Moreno I, et al. Outcomes of balloon occlusion in the University of California Morbidly Adherent Placenta Registry. Am J Obstet Gynecol MFM 2020; 2:100065.</a></li><li><a class="nounderline abstract_t">Salim R, Chulski A, Romano S, et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. Obstet Gynecol 2015; 126:1022.</a></li><li><a class="nounderline abstract_t">Chen M, Liu X, You Y, et al. Internal Iliac Artery Balloon Occlusion for Placenta Previa and Suspected Placenta Accreta: A Randomized Controlled Trial. Obstet Gynecol 2020; 135:1112.</a></li><li><a class="nounderline abstract_t">Carnevale FC, Kondo MM, de Oliveira Sousa W Jr, et al. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta. Cardiovasc Intervent Radiol 2011; 34:758.</a></li><li><a class="nounderline abstract_t">Chen L, Wang X, Wang H, et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2019; 19:30.</a></li><li><a class="nounderline abstract_t">Ordoñez CA, Manzano-Nunez R, Parra MW, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: A systematic review, meta-analysis, and case series. J Trauma Acute Care Surg 2018; 84:809.</a></li><li><a class="nounderline abstract_t">Stensaeth KH, Sovik E, Haig IN, et al. Fluoroscopy-free Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for controlling life threatening postpartum hemorrhage. PLoS One 2017; 12:e0174520.</a></li><li><a class="nounderline abstract_t">Nieto-Calvache AJ, Hidalgo-Cardona A, Lopez-Girón MC, et al. Arterial thrombosis after REBOA use in placenta accreta spectrum: a case series. J Matern Fetal Neonatal Med 2022; 35:4031.</a></li><li><a class="nounderline abstract_t">Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. Anesth Analg 2018; 127:930.</a></li><li><a class="nounderline abstract_t">Selman AE. Caesarean hysterectomy for placenta praevia/accreta using an approach via the pouch of Douglas. BJOG 2016; 123:815.</a></li><li><a class="nounderline abstract_t">Belfort MA, Shamshirsaz AA, Fox KA. A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy. Am J Obstet Gynecol 2017; 217:222.e1.</a></li><li><a class="nounderline abstract_t">Milne ME, Yazer MH, Waters JH. Red blood cell salvage during obstetric hemorrhage. Obstet Gynecol 2015; 125:919.</a></li><li><a class="nounderline abstract_t">Albright CM, Rouse DJ, Werner EF. Cost savings of red cell salvage during cesarean delivery. Obstet Gynecol 2014; 124:690.</a></li><li><a class="nounderline abstract_t">Khan KS, Moore PAS, Wilson MJ, et al. Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO). PLoS Med 2017; 14:e1002471.</a></li><li><a class="nounderline abstract_t">Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009; 116:648.</a></li><li><a class="nounderline abstract_t">Wright JD, Bonanno C, Shah M, et al. Peripartum hysterectomy. Obstet Gynecol 2010; 116:429.</a></li><li><a class="nounderline abstract_t">Soleymani Majd H, Collins SL, Addley S, et al. The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): a systematic, safe procedure for the management of severe placenta accreta spectrum. Am J Obstet Gynecol 2021; 225:175.e1.</a></li><li><a class="nounderline abstract_t">Lumbreras-Marquez MI, Singh S, King CH, et al. Rotational thromboelastometry for the transfusion management of postpartum hemorrhage after cesarean or vaginal delivery: A single-center randomized controlled trial. J Gynecol Obstet Hum Reprod 2022; 51:102470.</a></li><li><a class="nounderline abstract_t">Amgalan A, Allen T, Othman M, Ahmadzia HK. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH. J Thromb Haemost 2020; 18:1813.</a></li><li><a class="nounderline abstract_t">Duenas-Garcia OF, Goldberg JM. Topical hemostatic agents in gynecologic surgery. Obstet Gynecol Surv 2008; 63:389.</a></li><li><a class="nounderline abstract_t">Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010; 251:217.</a></li><li><a class="nounderline abstract_t">Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm 2006; 63:1244.</a></li><li><a class="nounderline abstract_t">Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24:288.</a></li><li><a class="nounderline abstract_t">Finan MA, Fiorica JV, Hoffman MS, et al. Massive pelvic hemorrhage during gynecologic cancer surgery: "pack and go back". Gynecol Oncol 1996; 62:390.</a></li><li><a class="nounderline abstract_t">Dildy GA, Scott JR, Saffer CS, Belfort MA. An effective pressure pack for severe pelvic hemorrhage. Obstet Gynecol 2006; 108:1222.</a></li><li><a class="nounderline abstract_t">Ghourab S, Al-Nuaim L, Al-Jabari A, et al. Abdomino-pelvic packing to control severe haemorrhage following caesarean hysterectomy. J Obstet Gynaecol 1999; 19:155.</a></li><li><a class="nounderline abstract_t">Awonuga AO, Merhi ZO, Khulpateea N. Abdominal packing for intractable obstetrical and gynecologic hemorrhage. Int J Gynaecol Obstet 2006; 93:160.</a></li><li><a class="nounderline abstract_t">Howard RJ, Straughn JM Jr, Huh WK, Rouse DJ. Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture. Obstet Gynecol 2002; 100:1061.</a></li><li><a class="nounderline abstract_t">Burchell RC. The umbrella pack to control pelvic hemorrhage. Conn Med 1968; 32:734.</a></li><li><a class="nounderline abstract_t">PARENTE JT, DLUGI H, WEINGOLD AB. Pelvic hemostasis: a new technic and pack. Obstet Gynecol 1962; 19:218.</a></li><li><a class="nounderline abstract_t">Cassels JW Jr, Greenberg H, Otterson WN. Pelvic tamponade in puerperal hemorrhage. A case report. J Reprod Med 1985; 30:689.</a></li><li><a class="nounderline abstract_t">Robie GF, Morgan MA, Payne GG Jr, Wasemiller-Smith L. Logothetopulos pack for the management of uncontrollable postpartum hemorrhage. Am J Perinatol 1990; 7:327.</a></li><li><a class="nounderline abstract_t">Hallak M, Dildy GA 3rd, Hurley TJ, Moise KJ Jr. Transvaginal pressure pack for life-threatening pelvic hemorrhage secondary to placenta accreta. Obstet Gynecol 1991; 78:938.</a></li><li><a class="nounderline abstract_t">Charoenkwan K. Use of the Bakri postpartum balloon in a patient with intractable pelvic floor hemorrhage: when other methods failed to stop postcesarean bleeding, physicians tried something new. Am J Obstet Gynecol 2013; 209:277.e1.</a></li><li><a class="nounderline abstract_t">Touhami O, Bouzid A, Ben Marzouk S, et al. Pelvic Packing for Intractable Obstetric Hemorrhage After Emergency Peripartum Hysterectomy: A Review. Obstet Gynecol Surv 2018; 73:110.</a></li><li><a class="nounderline abstract_t">Briery CM, Rose CH, Hudson WT, et al. Planned vs emergent cesarean hysterectomy. Am J Obstet Gynecol 2007; 197:154.e1.</a></li><li><a class="nounderline abstract_t">van den Akker T, Brobbel C, Dekkers OM, Bloemenkamp KWM. Prevalence, Indications, Risk Indicators, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis. Obstet Gynecol 2016; 128:1281.</a></li><li><a class="nounderline abstract_t">Shellhaas CS, Gilbert S, Landon MB, et al. The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol 2009; 114:224.</a></li><li><a class="nounderline abstract_t">Wilson RD, Caughey AB, Wood SL, et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol 2018; 219:523.e1.</a></li></ol></div><div id="topicVersionRevision">Topic 5395 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27824750" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36701608" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Incidence, Indications, Risk Factors, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17138784" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Incidence and determinants of peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19229546" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Incidence, trends, risk factors, indications for, and complications associated with cesarean hysterectomy: a 17-year experience from a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25845622" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Emergency peripartum hysterectomy: results from the prospective Nordic Obstetric Surveillance Study (NOSS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27825028" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Peripartum hysterectomy incidence, risk factors and clinical characteristics in Ireland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27349293" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Population-based risk for peripartum hysterectomy during low- and moderate-risk delivery hospitalizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27262500" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Risk of peripartum hysterectomy in births after assisted reproductive technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31520414" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Women undergoing peripartum hysterectomy due to obstetric hemorrhage: A prospective population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29843627" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Risk factors for peripartum hysterectomy among women with postpartum haemorrhage: analysis of data from the WOMAN trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310378" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Peripartum hysterectomy: 1999 to 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19546767" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Factors associated with peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177297" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19306969" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Changing trends in peripartum hysterectomy over the last 4 decades.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27560802" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Potentially Avoidable Peripartum Hysterectomies in Denmark: A Population Based Clinical Audit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22617577" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Placental and uterine pathology in women undergoing peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27810552" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Management and outcome of cervical cancer diagnosed in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26241269" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17877772" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23924326" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21898078" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Predicting factors for emergency peripartum hysterectomy in women with placenta previa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9240608" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Clinical risk factors for placenta previa-placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16738145" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Maternal morbidity associated with multiple repeat cesarean deliveries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32358968" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Epidemiological analysis of peripartum hysterectomy across nine European countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18165397" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Cesarean delivery and peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21309195" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20502289" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Morbidity and mortality of peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20537305" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Determinants and complications of emergent cesarean hysterectomy: supracervical vs total hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33645414" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The effect of surgical procedure on surgical outcomes in patients undergoing emergency peripartum hysterectomy: a retrospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28098341" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33910145" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Internal iliac artery balloon occlusion in the management of placenta accreta: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17954654" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17904978" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22831808" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30667043" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Internal iliac artery balloon occlusion during cesarean hysterectomy in women with placenta previa accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33345981" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Outcomes of balloon occlusion in the University of California Morbidly Adherent Placenta Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26444128" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32282608" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Internal Iliac Artery Balloon Occlusion for Placenta Previa and Suspected Placenta Accreta: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21598085" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646863" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29401189" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: A systematic review, meta-analysis, and case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28355242" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fluoroscopy-free Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for controlling life threatening postpartum hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33207992" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Arterial thrombosis after REBOA use in placenta accreta spectrum: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29481427" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26642997" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Caesarean hysterectomy for placenta praevia/accreta using an approach via the pouch of Douglas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28487113" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A technique to positively identify the vaginal fornices during complicated postpartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25751212" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Red blood cell salvage during obstetric hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25198270" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cost savings of red cell salvage during cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29261655" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19191778" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Optimal management strategies for placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20664405" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Peripartum hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33716074" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): a systematic, safe procedure for the management of severe placenta accreta spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36070853" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Rotational thromboelastometry for the transfusion management of postpartum hemorrhage after cesarean or vaginal delivery: A single-center randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32356929" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18492295" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Topical hemostatic agents in gynecologic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20010084" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A comprehensive review of topical hemostatic agents: efficacy and recommendations for use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16790576" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Absorbable hemostatic agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17657154" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Use of topical hemostatic agents during liver resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8812538" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Massive pelvic hemorrhage during gynecologic cancer surgery: "pack and go back".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17077246" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : An effective pressure pack for severe pelvic hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15512258" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Abdomino-pelvic packing to control severe haemorrhage following caesarean hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16549068" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Abdominal packing for intractable obstetrical and gynecologic hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12423804" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5683620" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The umbrella pack to control pelvic hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14483830" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pelvic hemostasis: a new technic and pack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3877165" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pelvic tamponade in puerperal hemorrhage. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2222620" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Logothetopulos pack for the management of uncontrollable postpartum hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1923235" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Transvaginal pressure pack for life-threatening pelvic hemorrhage secondary to placenta accreta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23816845" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Use of the Bakri postpartum balloon in a patient with intractable pelvic floor hemorrhage: when other methods failed to stop postcesarean bleeding, physicians tried something new.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29480925" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pelvic Packing for Intractable Obstetric Hemorrhage After Emergency Peripartum Hysterectomy: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17689631" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Planned vs emergent cesarean hysterectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27824773" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Prevalence, Indications, Risk Indicators, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19622981" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The frequency and complication rates of hysterectomy accompanying cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30240657" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
